DoW Peer Reviewed Medical, Lifestyle and Applied Health Research Award

The Lifestyle and Applied Health Research Award is administered by the Defense Health Agency through the Congressionally Directed Medical Research Programs, which operates under the U.S. Department of Defense to support high-impact medical research aligned with military health priorities. Established in 1999, the broader program has received substantial congressional appropriations to fund research that directly benefits Service Members, Veterans, and their families. This specific award mechanism focuses on advancing clinical research and clinical trials that improve health outcomes, quality of life, and patient-centered care using interdisciplinary approaches grounded in applied health sciences. The primary purpose of this funding opportunity is to support clinical research and clinical trials that investigate nonpharmacological interventions, noninvasive devices, and healthcare delivery approaches. Projects must address one congressionally directed topic area and align with one strategic goal within the program’s defined research portfolios. The program emphasizes evidence-based, patient-centered outcomes and encourages studies that examine behavioral, cognitive, and social determinants of health, as well as interventions that improve prevention, diagnosis, treatment, or quality of life. Animal studies and trials involving regulated pharmacological interventions or invasive devices are explicitly excluded. Funding for this opportunity is substantial, with approximately 16.8 million dollars allocated to support about four awards. Each award has a total cost cap of 4.2 million dollars over a maximum performance period of four years. Funds may be used for a wide range of research-related expenses, including personnel, data collection, and limited travel for collaboration and dissemination. However, certain restrictions apply, such as limits on travel funding and a prohibition on tuition costs. Cost sharing is not required, which lowers barriers to entry for eligible applicants. Eligibility is broad and inclusive, allowing applications from both domestic and international organizations, including for-profit and nonprofit entities, public and private institutions, and government organizations. Independent investigators affiliated with eligible organizations may serve as Principal Investigators, provided they meet institutional criteria. Applications must include patient advocate participation, ensuring that research remains grounded in real-world patient needs and experiences. The patient advocate must be actively involved throughout the project lifecycle, from design to evaluation. The application process follows a two-step submission structure. Applicants must first submit a pre-application in the form of a Letter of Intent through the eBRAP system, followed by a full application submitted through either eBRAP or Grants.gov depending on organizational type. The full application requires extensive documentation, including a project narrative, supporting documentation, abstracts, a statement of work, and multiple compliance and planning attachments. Applications are evaluated through a two-tier review process consisting of peer review and programmatic review, with criteria focusing on impact, feasibility, study design, and relevance to military health. The timeline for this funding opportunity includes a pre-application deadline in late July and a full application deadline in early August. Following submission, applications undergo peer review in the fall and programmatic review in early the following year, with funding decisions expected thereafter. Awards are anticipated to be issued by September of the following fiscal cycle, and funded projects must adhere to strict reporting and compliance requirements throughout the period of performance. Overall, this funding opportunity is designed to accelerate the translation of applied health research into meaningful clinical improvements, particularly for military populations. By prioritizing interdisciplinary collaboration, patient engagement, and near-term impact, the program seeks to generate actionable knowledge and interventions that enhance healthcare delivery and patient outcomes both within military systems and the broader civilian population.

Ensure strong alignment with a congressionally directed topic area and strategic goal; integrate patient advocate meaningfully throughout project; clearly demonstrate relevance to military health; provide rigorous study design with strong statistical justification